A detailed history of Whalerock Point Partners, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Whalerock Point Partners, LLC holds 7,506 shares of ABT stock, worth $780,774. This represents 0.24% of its overall portfolio holdings.

Number of Shares
7,506
Previous 7,506 -0.0%
Holding current value
$780,774
Previous $826,000 3.27%
% of portfolio
0.24%
Previous 0.26%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$90.19 - $110.4 $9,019 - $11,040
-100 Reduced 1.31%
7,506 $826,000
Q2 2023

Aug 14, 2023

BUY
$100.78 - $112.29 $20,659 - $23,019
205 Added 2.77%
7,606 $829,000
Q4 2022

Feb 13, 2023

BUY
$95.06 - $111.52 $137,361 - $161,146
1,445 Added 24.26%
7,401 $812,000
Q3 2022

Nov 16, 2022

BUY
$96.76 - $112.03 $520,568 - $602,721
5,380 Added 934.03%
5,956 $576,000
Q3 2022

Nov 15, 2022

SELL
$96.76 - $112.03 $520,568 - $602,721
-5,380 Reduced 90.33%
576 $576 Million
Q1 2021

May 13, 2021

BUY
$108.84 - $128.23 $32,652 - $38,469
300 Added 5.3%
5,956 $713,000
Q4 2020

Feb 12, 2021

BUY
$105.0 - $114.42 $529,200 - $576,676
5,040 Added 818.18%
5,656 $619,000
Q3 2020

Nov 13, 2020

SELL
$91.64 - $111.29 $461,865 - $560,901
-5,040 Reduced 89.11%
616 $67,000
Q1 2020

May 15, 2020

SELL
$62.82 - $91.86 $6,282 - $9,186
-100 Reduced 1.74%
5,656 $446,000
Q3 2019

Nov 12, 2019

SELL
$81.84 - $88.74 $3,600 - $3,904
-44 Reduced 0.76%
5,756 $482,000
Q1 2019

May 13, 2019

BUY
$66.22 - $80.06 $122,771 - $148,431
1,854 Added 46.98%
5,800 $464,000
Q2 2018

Mar 04, 2019

SELL
$57.57 - $63.54 $50,316 - $55,533
-874 Reduced 18.13%
3,946 $241,000
Q1 2018

Apr 05, 2018

SELL
$56.27 - $63.62 $4,220 - $4,771
-75 Reduced 1.53%
4,820 $288,000
Q4 2017

Jan 16, 2018

BUY
$53.68 - $57.47 $7,032 - $7,528
131 Added 2.75%
4,895 $279,000
Q3 2017

Oct 31, 2017

BUY
$48.06 - $53.64 $228,957 - $255,540
4,764
4,764 $254,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $182B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Whalerock Point Partners, LLC Portfolio

Follow Whalerock Point Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Whalerock Point Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Whalerock Point Partners, LLC with notifications on news.